Sign In

Adam Johns

Executive Director, Digital, Methods and Modeling Lead, Oncology Global Value & Access at Novartis

Adam Johns is an experienced professional in health economics, market access, and data science, currently serving as the Executive Director, Digital, Methods and Modeling Lead for Global Value & Evidence in Oncology at Novartis. He has a diverse educational background, including a Master of Information and Data Science (MIDS) from UC Berkeley School of Information, specializing in data science, data engineering, and machine learning.1

Prior to his current role at Novartis, Adam held several significant positions in the pharmaceutical and healthcare industry:

  1. Principal of Pricing and Market Access at ICON plc (2016-2019)1
  2. Director of Payer Insights and Access in Oncology at Pfizer (2012-2016)1
  3. Outcomes Research Manager in Oncology at Pfizer (2009-2012)1
  4. Health Outcomes Scientist in European Outcomes Research at Eli Lilly and Company (2008-2009)1

Adam's educational background includes:

  • Master of Science in International Health Policy - Health Economics from the London School of Economics and Political Science1
  • Bachelor of Science in Science and Business, Economics from the University of Waterloo1

His expertise spans health economics, market access, data science, and real-world evidence, making him well-suited for his current role in leading digital methods and modeling for oncology value and access at Novartis.1

Highlights

Early Diagnosis of Pancreatic Cancer via Machine Learning ...

Related Questions

What are Adam Johns' main responsibilities at Novartis?
How did Adam Johns' education prepare him for his role at Novartis?
What projects has Adam Johns led at Novartis?
How has Adam Johns' career evolved over the years?
What are some notable achievements of Adam Johns in the field of oncology?
Adam Johns
Add to my network

Location

New York, New York, United States